Location: Home
  • search
  • go
  • Relate News
  • 3/11/2026Peak Perform Innova Raises ~CNY 100M Angel Round to Advance PPI Drug D...
  • 3/10/2026China's Average Life Expectancy Hits 79.25 Years in 2025: NHC
  • 3/10/2026Hutchmed Withdraws Tazverik from China Following Safety Concerns
  • 3/10/2026China Patent Expiry and New GLP-1 Drugs Spark Global Obesity Drug Comp...
  • 3/10/2026Junshi Secures NMPA Acceptance for Subcutaneous Toripalimab Across 12 ...
  • 3/10/2026Novo Nordisk and United Labs Report ~20% Weight Loss With Next‑Gen Tr...
  • 3/10/2026US Weighs Policy Measures to Address China Biotech Competition
  • 3/10/2026China Biotech Dealmaking Defies Seasonal Slowdown as February Licensin...
  • 3/9/2026China Biotech Financing Rebounds in Early 2026 as RNA Deals and Global...
  • 3/9/2026Abbisko's Pimicotinib Phase 3 MANEUVER Results Published in The Lancet
  • 3/9/2026Merck KGaA Drops Hengrui-Licensed PARP1 Candidate After Early Clinical...
  • 3/9/2026iCamuno Biothera Raises Over CNY 100M in Series A3 to Advance iPSC Cel...
  • 3/9/2026Kelun Biotech and Harbour BioMed's SKB575 Receives IND Clearance in Ch...
  • 3/9/2026NMPA Seeks Input on Draft Guidelines for Quality Summaries of Therapeu...
  • 3/6/2026Lynk's Zemprocitinib Meets Phase III Endpoints in Atopic Dermatitis
  • 3/6/2026China Approves Novo's Weekly Insulin–GLP-1 Combination Therapy for Ty...
  • 3/6/2026Recent Executive Moves
  • 3/5/2026CMS Wins China Trial Approval for INHBE-Targeting Obesity siRNA Drug
  • 3/4/2026Sanofi Licenses Sino Biopharm's Transplant Therapy in $135M Upfront De...
  • 3/4/2026Minwei Biotech's siRNA Therapy MWX401 Cleared for Clinical Trials in C...
  • 3/4/2026Immunofoco Raises ~CNY 200M in Pre-IPO Round Ahead of Hong Kong Listin...
  • 3/4/2026Leman Biotech Raises ~CNY 200M to Advance Metabolism-Enhanced CAR-T Pl...
  • 3/4/2026CDE Invites Feedback on Draft Technical Guideline for Preventive mRNA ...
  • 3/4/2026China Biotech Outlicensing Surges Past US$52 Billion in Early 2026
  • 3/3/2026Prolium Launches with $50M to Advance China-Licensed T-Cell Engager in...
  • 3/3/2026Clickmab Biotech Secures Seed+ Funding to Boost AI Antibody Design Pla...
  • 3/3/2026LongBio Pharma's LP‑003 Shows Superior Efficacy Over Xolair in Phase ...
  • 3/2/2026WuXi XDC Partners With Earendil Labs on Next-Generation ADC Platform
  • 3/2/2026Sanofi Secures Two New China Approvals for Dupilumab
  • 3/2/2026NMPA Grants Conditional Approval to Sosimerasib for KRAS G12C-Mutant N...
  • Page:1/382 Total number of articles:11433: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group